02
Sep
2010
30
Aug
2010
23
Aug
2010
23
Aug
2010
18
Aug
2010
18
Aug
2010
17
Aug
2010
17
Aug
2010
13
Aug
2010
12
Aug
2010
Posted in I - Series B, Q - 3Q10, R - NORTH EAST, X - Cardiology, X - G-Protein, X - Pain, XX - PA
Trevena (Berwyn, PA) a clinical-stage small molecule company focused on G-protein coupled receptor targeting for heart failure and pain, closed a $35M Series B funding from existing investors. Participants include Polaris Venture Partners, New Enterprise Associates, Alta Partners, Healthcare Ventures and Yasuda Enterprise Development Company.